Plenary Session
386 episodes - English - Latest episode: 12 days ago - ★★★★★ - 722 ratingsA podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail [email protected]
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
5.32 - ASH Update #1 - Talquetamab NEJM
December 11, 2022 19:39 - 17 minutes - 16.3 MBIs it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.
5.31 - MUST LISTEN Grand Rounds - COVID19 Updates
December 08, 2022 18:59 - 55 minutes - 50.1 MBIn this lecture given December 7, 2022, I cover 5 things: Vaccines Masking Long COVID Schools/Immunity Debt Paxlovid
5.30 Rajkumar vs Goodman; Long COVID vs Long URI
December 03, 2022 20:19 - 40 minutes - 74.3 MBShould we treat smoldering MM, a debate Long COVID vs Long URI Review the show; Say Hi at ASH22
5.29 Smart Start is a useless Lymphoma study
November 27, 2022 01:13 - 49 minutes - 91.3 MBSmart Start is a useless lymphoma study; We have to stop putting our careers ahead of patients. In the second part, I discuss the 'experts' featured on STAT. Wowzers. I will be at ask. Hit me up: [email protected]
5.28 - Pandemic Amnesty or Accountability with Paul Fenyves
November 12, 2022 03:26 - 38 minutes - 70 MBI am joined by Cornell Professor Paul Fenyves; a practicing internist Dr. Fenyves walks us through COVID19 policy. We will be back soon with more cancer medicine. Including a devastating lymphoma one.
5.27 - Multiple Myeloma - Do Our Trials Help Patients?
November 08, 2022 21:24 - 28 minutes - 51.9 MBI was invited to give this talk to a UK conference on Myeloma Please LEAVE A REVIEW of this podcast
Multiple Myeloma - Do Our Trials Help Patients?
November 08, 2022 21:24 - 28 minutes - 51.9 MBI was invited to give this talk to a UK conference on Myeloma Please LEAVE A REVIEW of this podcast
5.26 - Hawaii Oncology Association Keynote Lecture
November 06, 2022 16:12 - 44 minutes - 80.6 MBLecture I gave this weekend in Hawaii to the Medical Oncology Association; One of the best audiences I've had
5.25 - Neurosurgery Grand Rounds by Vinay Prasad
November 03, 2022 04:36 - 1 hour - 132 MBI give Grand Rounds to UCSF Neurosurgery on how to read and interpret Neurosurgery Studies (Video and slides coming soon to YouTube) Also I discuss Bob Califf's Promotion of Paxlovid
5.24 Vlad Kogan is back to discuss Kids Test Scores
November 01, 2022 14:25 - 1 hour - 146 MBLearning Loss is Devastating; Here are the data and what it means
5.24 - Gerald Hsu MD PhD UCSF Heme Onc Program Director
October 28, 2022 03:02 - 1 hour - 125 MBLearn about UCSF Hematology Oncology Program with Dr. Gerald Hsu, MD PhD Malignant Heme and Program Director
5.23 - Subclinical Myocarditis
October 19, 2022 23:30 - 12 minutes - 23.1 MBA new study from Switzerland confirms the rate of subclinical myocarditis
5.23 - ID Ethicist joins me for a 6th discussion of COVID19 policy
October 18, 2022 16:07 - 1 hour - 163 MBLONG COVID, Vaccines, Paxlovid and More
5.22 NordICC trial interview with PI Michael Bretthauer - Offer but don't Nudge
October 15, 2022 00:59 - 1 hour - 126 MBdiscuss NordICC with the trial PI Power calc specified 50% non-adherence ADR is on par with US studies from the time Colo quality good Perf rate lower than US! How does he counsel individuals & governments What he thinks of USPSTF
5.21 Science Mag Editor Condemns Ladapo But Silent About Jha
October 14, 2022 03:19 - 34 minutes - 32 MBA double standard to condemn data with limitations, based on political party, will destroy medicine. We will back to oncology soon, but this is important
5.20 The Great Colonoscopy Debate
October 11, 2022 18:00 - 1 hour - 112 MBCifu, Mandrola and Prasad fight about colonoscopy
5.19 - NEJM's first ever RCT of Colonoscopy-- Explained
October 09, 2022 22:23 - 30 minutes - 56.5 MBI break down the history and data for the first ever randomized trial of colonoscopy, appearing in NEJM on Oct 9, 2022
5.18 Lecture to Heme Onc Fellows - POLO; Javelin 100 bladder
October 08, 2022 15:39 - 46 minutes - 85.5 MBPolo Javelin 100 bladder Crossover Control arms How to read and keep up with the literature
5.17 - The State Of Precision Oncology
October 07, 2022 00:48 - 15 minutes - 27.5 MBInvited Lecture to Cancer Center Directors
5.13 - The State Of Precision Oncology
October 07, 2022 00:48 - 15 minutes - 27.5 MBInvited Lecture to Cancer Center Directors
5.16 - Aaron Goodman UCSD
September 29, 2022 19:54 - 1 hour - 173 MBI travel to UCSD to interview Dr. Goodman about myeloma, celebrity oncology culture, his career, education, patient care, choosing a specialty and more.
5.15 - How To Apply For And Get Your Perfect First Job
September 21, 2022 21:40 - 36 minutes - 66.2 MBBased on listener questions, I discuss how to apply for and get your first job.
Unspoken Rules of Oncology - Malignant BC Part 6
September 18, 2022 00:21 - 1 hour - 115 MBT.O. joins me for the missing episode. These are the unspoken rules of Oncology; We dive deeper into Malignant Book Club.
Malignant Book Club - Episode 7 - famous trials
September 09, 2022 16:28 - 41 minutes - 76.3 MBTimothee Olivier joins me for the 7th installment of our book-club We cover famous trials in oncology
5.12 - Academics Vs Industry - A.Goodman S.Loghavi D.Steensma V.P.
September 03, 2022 01:35 - 1 hour - 164 MBHow do careers vary between the academy and industry? We have a panel of the best: Sanam Loghavi from MD Anderson, Aaron Goodman UCSD, and David Steensma Novartis (formerly Farber/ Mayo) and VP #Real talk
5.11 - Malignant Book Club - Part 5
August 26, 2022 00:38 - 52 minutes - 48.2 MBTimothee Olivier joinrs me as we explore part 3 of the book Crossover, sample size, observational vs RCTs
5.10 - Adam Cifu on clinical excellence
August 24, 2022 15:57 - 1 hour - 62.3 MBAdam Cifu is here to discuss clinical excellence and his new podcast
5.09 - Malignant Book Club Part 4
August 22, 2022 00:25 - 1 hour - 55.1 MBT.O. joins me to grill me on the rest of Financial Conflict of Interest and Precision Oncology. We discuss the need for randomization, and when it can be omitted. A must listen for Oncology Fans.
5.08 - LaceWing RCT Phase 3 Blood - Spin Cycle
August 18, 2022 16:44 - 33 minutes - 61.4 MBVP discusses the LaceWing study in Blood. A Phase 3 RCT of GILT AZA vs AZA; Medical writers; confounding; table 1; balance; and so much more
5.07 - Plenary Session Alps Edition
August 10, 2022 06:36 - 58 minutes - 54 MBTimothee Olivier joins me to discuss recent papers: IMPOWER10 Checkmate 816 Path CR/ EFS/ Surrogates Drug Dosing, cGCSF rules and more Bread and butter oncology
5.06 - POLO trial now has OS results - OMG
July 21, 2022 01:03 - 30 minutes - 28.1 MBThe POLO trial, which we first broke on PS Season 1- is back with null OS results. But the trial authors enter the spin cycle. VP goes line by line.
5.05 - Citations, Metrics, Rankings in Oncology & Medicine
July 18, 2022 05:38 - 36 minutes - 33.5 MBVP explains H index, total cites, papers, US News and World Report rankings and how evaluates researchers and doctors.
5.04 - Citations, Metrics, Rankings in Oncology & Medicine
July 18, 2022 05:38 - 36 minutes - 33.5 MBVP explains H index, total cites, papers, US News and World Report rankings and how evaluates researchers and doctors.
5.04 - Echelon 1 reports OS benefit - But does it add up?
July 14, 2022 23:54 - 39 minutes - 35.9 MBVP addresses what to do you if you get an idea from listening to the show, and deconstructs ECHELON-1. Instead of listening we highly recommend you watch the video on YouTube with graphics. This is worth the watch.
5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?
July 13, 2022 04:59 - 51 minutes - 46.8 MBHow to think about when and how to do RCTs? What are the limitations to observational studies? Smoking. Parachutes. Dostarlimab. Guarantee Time Bias. Confounding. Multiple Hypothesis testing and more
5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers
July 11, 2022 01:27 - 46 minutes - 42.6 MBI make the case why this podcast should be your go to for Med, Onc & Policy. I describe my philosophy of Evidence, Empiricism, and show how this connects to many oncology studies. I answer a bunch of Listener Questions
5.01 - How To Read Randomized Trials In Cancer
July 07, 2022 23:58 - 37 minutes - 34.6 MBHow to read randomized trials in cancer medicine. Phase 2 vs 3, control arm, crossover, post protocol, censoring (the basics), and how law professors and medical professors are different and why it matters.
Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health
June 22, 2022 05:31 - 19 minutes - 17.4 MBLies and Exaggerations about Kids Vaccine I give examples, and show why they are lies
Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer
June 20, 2022 14:19 - 14 minutes - 13.7 MBWhat happens when you treat people with $168,000 a year medicine when most of them will never need treatment, and all of them don't need treatment now
Kids Vaccine For Under 5 years Old
June 18, 2022 22:56 - 42 minutes - 39 MBI take a deep dive into the data for the mRNA vaccines for kids under 5 years olds
H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189
June 18, 2022 02:54 - 1 hour - 70.6 MBI sit down with H Jack West. City of Hope. Thoracic Oncology and we have a long discussion about trials; staging; PDL1 thresholds; Driver mutations and post protocol care; ADAURA; Adjuvant; & More
QuANTUM - Quizartinib Front Line - Ethics of Global Trials
June 15, 2022 13:16 - 41 minutes - 38.3 MBI discuss the timeline of Ratify and Quantum. Was this an ethical trial? Is it sufficient to say a trial is ethical because 50% of participants get something?
4.67 Teclistimab for R/R Multiple Myeloma
June 09, 2022 22:56 - 37 minutes - 34.5 MBThe drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
2.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??
June 08, 2022 14:23 - 24 minutes - 22.2 MBAre the results from Luis Diaz as good as touted. What trial should they do going forward? A 100% CR rate in Stage II and III rectal cancer??
4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??
June 08, 2022 14:23 - 24 minutes - 22.2 MBAre the results from Luis Diaz as good as touted. What trial should they do going forward? A 100% CR rate in Stage II and III rectal cancer??
4.57 DESTINY BREAST 04 - A complex trial to deconstruct
June 07, 2022 14:25 - 29.5 MBMy take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
4.65 DESTINY BREAST 04 - A complex trial to deconstruct
June 07, 2022 14:25 - 32 minutes - 29.5 MBMy take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
4.64 - DETERMINATION - Should we still use transplant Myeloma?
June 06, 2022 14:52 - 31 minutes - 29.2 MBI break down Richardson, et al. NEJM DETERMINATION Transplanters are determined to keep going, should they be? Watch the videos b/c I have lots of great visuals My ASCO Coverage continues
4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer
June 05, 2022 23:14 - 35 minutes - 32.5 MBThe second paper from #ASCO2022 #ASCO22 that I break down This is one of the most technical papers I breakdown on the channel CT DNA used to omit chemo in Stage II colon cancer Read the book Malignant if you learn from this Watch the YouTube Figures https://youtu.be/QxOBIi7I2BU
4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial
June 04, 2022 19:33 - 18 minutes - 16.5 MBContinuous vs. Fixed, 3 vs 2, PFS is the primary endpoint No OS Bad crossover Lots to discuss here I will be covering all the major ASCO papers on @PlenarySession Subscribe to my substack https://vinayprasadmdmph.substack.com/